Media Resources

Explore the latest Lantheus news and information including all current and archived press releases. You can also sign up to receive email alerts.

Media Contact

Melissa Downs Director, Corporate Communications
646-975-2533

Press Releases

Lantheus Holdings Announces Submission of Drug Master File for NM-01 in the U.S.

Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent

PyL™ (18F-DCFPyL), Lantheus’ PSMA-Targeted Prostate Cancer Imaging Agent, to be Used in POINT Biopharma’s PSMA-Targeted Radioligand Therapeutic Phase 3 Trial in Patients with Metastatic Castration Resistant Prostate Cancer

Lantheus Holdings, Inc. Announces Agreement to Sell Its Puerto Rico Radiopharmacy and PET Manufacturing Facility and Enter into Long-Term Supply Agreement

Lantheus Holdings to Present at the 2020 Evercore ISI HealthCONx Conference